ClearPoint Neuro Inc vs ArcelorMittal SA — how do they compare? ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M), while ArcelorMittal SA trades at $75.17 (market cap $55.88B). The key difference: ArcelorMittal SA is far larger — about 123× ClearPoint Neuro Inc's market cap, and ArcelorMittal SA pays a 0.81% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| CLPT | MT | |
|---|---|---|
Market Cap | $454.21M | $55.88B |
Sector | Health | Basic Materials |
52-Week High | $29.60 | $75.35 |
52-Week Low | $8.66 | $32.44 |
Enterprise Value | $488.79M | $65.45B |
Dividend Yield | — | 0.81% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ArcelorMittal (MT) trades at $73.90, up 0.83% with bullish technical signals and strong institutional support. The stock shows improving fundamentals with Q2 2026 revenue growth despite an earnings miss, while maintaining stable dividends. Recent news highlights strategic partnerships and European business recovery prospects.
Outlook remains cautiously optimistic with 50% analyst buy ratings, though risks include cyclical steel demand and margin pressures. The current P/E of 30.97 appears elevated relative to historical norms, requiring sustained earnings growth to justify valuation.
Trailing returns across standard periods
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →